Nanobio and Nanomedicine

MAD Nanolayers has developed a polymer coating capable of releasing multiple drugs in a sequential manner, all from a single nanometer-thin coating that is highly uniform and conformal.

Provides integrated systems for nanotechnology-based cancer therapy.

MagnaMedics is active in the field of developing and commercializing Nano tools and systems for Life Science Research, analytical laboratories, medical diagnostics and therapies.

Develops tissue engineering products by using magnetic nanoparticles to overcome major problems associated with the ex vivo growth of human tissues and cells.

MSI's technology for multi-step multi-analyte chemiluminescent assays combines microfluidics, nanotechnology, and optoelectronics designed for both Immunoassay and Nucleic Acid Hybridization based applications.

The company is focused on realizing the potential of RNAi-based therapeutics through the development of a broad-based, state-of-the-art drug discovery platform built upon industry leading expertise in RNA chemistry and oligonucleotide delivery.

The company utilizes its proprietary nanotechnology platform to transform existing and experimental anti-cancer agents into new, patentable drugs with superior pharmaceutical properties.

A provider of microchip-based biosample preparation systems for the biodefense and genomics industries by exploiting its proprietary microfluidic and nanofluidic technologies.

The company's Nanosil™ Microarray Substrate, a nanometal fluorescence-enhancing substrate, is a biochip for biomedical analytical applications.

Micronics, Inc. is a leading developer of near patient in vitro diagnostic products for disease diagnosis, prognosis and treatment monitoring. Capabilities include micro-nano assays.

Micronit Microfluidics focuses on developing, prototyping and manufacturing lab-on-a-chip products. Micronit has extensive experience supplying microfluidic solutions to the life sciences industry. Capabilities include nanofluidic channels (depth down to 100 nm).

The MicroTransponder, Inc. technology portfolio consists of a wireless micro-system that can interface with peripheral nerves and a host of biochemical micro/nano- sensors.

Design, synthesis and manufacture of biocompatible nanoparticles called nanocells.

Mindseeds Laboratories is a start-up company focused on research and engineering of innovative platforms for single-cell processing, manipulation and analysis.

Develops nanoparticle based in vivo delivery applications.

The Company's lead product in development is a passive, nano-film Hydroxyapatite (HAp) coating. In parallel, the Company is developing a multi-layer nano-film coating with drug-eluting capabilities to facilitate therapeutics and treatments for localized drug delivery systems.

MMI is a leading company providing scientists with innovative and sophisticated instruments which introduced the use of solid state laser capture microdissection, making this core technology in many scientific fields more efficient and cost effective. The patented adhesive cap is reliable, clean and easy to use. The company's products range from laser microdissection systems and optical tweezers to single cell technologies.

Molecular Profiles provides advanced, including nanoscale, analytical research for the pharmaceutical and healthcare industry.

Molecular Targets uses nanotechnology to develop diagnostic kits that will allow for the early detection of certain types of metabolic diseases.